SEHK:3788
SEHK:3788Metals and Mining

A Look At China Hanking Holdings (SEHK:3788) Valuation After Leadership Changes And Follow On Equity Offering

China Hanking Holdings (SEHK:3788) has just combined a leadership shake up with fresh fundraising plans by appointing a new CEO and chairman, while filing a HK$782.8m follow on equity offering at HK$3.80 per share. See our latest analysis for China Hanking Holdings. The leadership overhaul and HK$782.8m follow on offering come after a sharp shift in market expectations, with a 30 day share price return of 33.24% and a very large 1 year total shareholder return. This suggests that momentum has...
SEHK:119
SEHK:119Real Estate

Poly Property Group (SEHK:119) Valuation Check After New Medium Term Note Issuance And Recent Share Price Gains

Poly Property Group (SEHK:119) caught investor attention after its subsidiary, Shanghai Poly Property, issued a second tranche of 2026 medium term notes. The issuance raised RMB500 million at a 2.95% coupon to replenish funds used for prior debt repayment. See our latest analysis for Poly Property Group. The recent RMB500 million note issuance comes at a time when Poly Property Group’s 90 day share price return of 23.24% and 1 year total shareholder return of 58.44% point to building momentum...
SEHK:3696
SEHK:3696Life Sciences

Assessing InSilico Medicine Cayman TopCo (SEHK:3696) Valuation After Strong Year To Date Share Price Gains

Setting the scene for InSilico Medicine Cayman TopCo InSilico Medicine Cayman TopCo (SEHK:3696) has drawn fresh attention after recent share price moves, with a 1 day return of about 1.6% and a 7 day gain of roughly 4.7%. See our latest analysis for InSilico Medicine Cayman TopCo. The latest moves sit within a much stronger trend, with a year to date share price return of about 58.9% at a current share price of roughly HK$59.7. This suggests momentum has been building as investors reassess...
SEHK:700
SEHK:700Interactive Media and Services

Tencent Gains First Access To Nvidia H200 Chips Raising AI And Valuation Stakes

Chinese regulators have approved Tencent Holdings and other major tech firms to purchase Nvidia's H200 artificial intelligence chips. This is the first time Tencent has received approval to import the H200 chips, which are used for advanced AI workloads. Tencent Holdings (SEHK:700) is trading at HK$621.0, with the share price up 56.1% over the past year and 65.3% over the past three years. The recent approval to access Nvidia's H200 chips arrives as Tencent continues to be a key player in...
SEHK:1211
SEHK:1211Auto

BYD (SEHK:1211) Valuation Check As P/E Premium Contrasts With Cash Flow Upside Signals

Recent share performance and business scale Without a clear single news catalyst, you might be looking at BYD (SEHK:1211) simply because its recent share performance and business size stand out among Hong Kong listed auto and battery groups. Over the past month, BYD shares have returned about 5.9%, while the past 3 months show a modest 1.3% decline. On a 1 year view, the total return figure provided is 14.2%. The company reports revenue of CN¥841.1b and net income of CN¥38.3b. This reflects a...
SEHK:1133
SEHK:1133Electrical

Harbin Electric (SEHK:1133) Valuation After 2025 Profit Forecast And Strong Equipment Order Outlook

Harbin Electric (SEHK:1133) has issued a profit forecast for fiscal 2025, indicating an expected increase in net profit tied to higher operating revenue, improved product profitability, and newly secured equipment orders. See our latest analysis for Harbin Electric. Harbin Electric’s recent 1-month share price return of 22.92% and 90-day gain of 52.66% to HK$20.38 suggest momentum is building. Its very large 1-year total shareholder return and strong multi year figures point to a sustained...
SEHK:1177
SEHK:1177Pharmaceuticals

Breakthrough Hepatitis B Drug TQA3605 Might Change The Case For Investing In Sino Biopharmaceutical (SEHK:1177)

Sino Biopharmaceutical recently reported that its independently developed Class I innovative drug TQA3605, a core protein allosteric modulator, met the primary endpoint in a randomized, double-blind, placebo-controlled Phase II trial in chronic hepatitis B patients on nucleos(t)ide analogues, significantly improving viral suppression with a generally favorable safety profile. Because no core protein allosteric modulator for hepatitis B is yet approved globally and diagnosis and treatment...
SEHK:3337
SEHK:3337Energy Services

3 Asian Penny Stocks With Market Caps Below US$2B

As global markets navigate a landscape marked by geopolitical uncertainties and economic fluctuations, investors are increasingly turning their attention to Asia's diverse financial ecosystem. Penny stocks, often characterized as smaller or newer companies, continue to capture interest due to their potential for growth and value discovery. While the term may seem outdated, these stocks can offer intriguing opportunities when backed by solid financials and strategic growth plans.
SEHK:992
SEHK:992Tech

Lenovo’s Platinum ESG Medal Adds New Dimension To Valuation Story

Lenovo Group (SEHK:992) has received a Platinum Medal from EcoVadis for business sustainability. The award places Lenovo among the top 1% of companies globally for ESG performance. The recognition reflects strong results in Environment and Ethics, alongside high ESG ratings from MSCI and CDP. For investors tracking Lenovo Group at around HK$8.88 per share, this new recognition adds an ESG angle to the investment story. Over the past 3 years the stock has returned 60.0%, and 13.5% over 5...
SEHK:939
SEHK:939Banks

A Look At China Construction Bank (SEHK:939) Valuation As Wealth Management Hiring In Hong Kong Accelerates

Wealth management hiring push puts China Construction Bank in focus China Construction Bank (SEHK:939) is back on investors’ radar after its Hong Kong arm outlined plans to hire 100 people over the next two years to grow its wealth management franchise. See our latest analysis for China Construction Bank. The hiring push in Hong Kong comes as China Construction Bank’s shares trade at HK$7.77, with a 30-day share price return of 2.78% but a 90-day share price return showing a 1.65% decline...